6533b855fe1ef96bd12b0842

RESEARCH PRODUCT

Dental implants in patients treated with oral bisphosphonates. A bibliographic review

José-maria Montoya-carraleroPiedad Ramírez-fernándezIsabel Maria Morata-murciaPablo Parra-minoMaria Del Carmen Mompeán-gambínJosé Luis Calvo-guirado

subject

medicine.medical_specialtymedicine.medical_treatmentOsteoporosisMEDLINEAdministration OralDentistryBone resorptionProstate cancerQuality of lifemedicineHumansDental implantGeneral DentistryMultiple myelomaDental ImplantsDiphosphonatesbusiness.industryOsteonecrosisBisphosphonatemedicine.disease:CIENCIAS MÉDICAS [UNESCO]SurgeryOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASSurgerybusinessJaw Diseases

description

Bisphosphonates inhibit bone resorption and are used to treat a range of pathologies, including Paget disease, osteoporosis, multiple myeloma and metastases associated with breast or prostate cancer. At present, there is no effective treatment for bisphosphonate induced osteonecrosis, so prevention is extremely important. Since quality of life deteriorates for those suffering osteonecrosis, maximum precautions should be taken with patients at risk, and especially whenever oral surgery, including dental implant placement, is contemplated. Dentists and oral or maxillofacial surgeons must keep up to date with the latest approaches to prevention, particularly when treating patients who are presently taking, or who will be taking bisphosphonates and are also candidates for dental implants.

yearjournalcountryeditionlanguage
2010-01-01
http://hdl.handle.net/10550/60400